Related Experiment Video
Updated: Oct 3, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Lung-borne systemic inflammation in mechanically ventilated infant rats due to high PEEP, oxygen, and hypocapnia
Philipp Baumann1,2, Francesco Greco1,2,3, Pietro L'Abate1,2
1Department of Intensive Care Medicine and Neonatology, University Children's Hospital Zurich Zurich, Switzerland.
Insights
Mechanical ventilation adjustments in infants, including positive end-expiratory pressure (PEEP) and fraction of inspired oxygen (FiO2), can trigger significant inflammatory responses. These findings highlight the need for lung-protective strategies in critical care settings.
Area of Science:
- Pediatric Critical Care Medicine
- Neonatal Physiology
- Respiratory Mechanics
Background:
- Critically ill children require frequent ventilator adjustments (PEEP, FiO2, RR) due to changing clinical conditions.
- The impact of specific ventilator setting alterations on systemic inflammation in infants is not well understood.
Purpose of the Study:
- To investigate how changes in positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO2), and respiratory rate (RR) affect systemic inflammatory markers in infant rats.
Main Methods:
- Wistar rat pups were exposed to various mechanical ventilation settings for 120 minutes.
- Groups included controls and variations in PEEP, FiO2, and respiratory rate (hypocapnia/hypercapnia).
- Plasma inflammatory biomarkers were analyzed post-ventilation.
Main Results:
- Elevated FiO2 (0.4 and 1.0) significantly increased Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α).
- High PEEP (9 cmH2O) and hypocapnia elevated tissue plasminogen activator inhibitor type-1 (tPAI-1).
- Hypercapnia showed a significant reduction in TNF-α.
Conclusions:
- Ventilator adjustments in PEEP, FiO2, and respiratory frequency induce systemic inflammation in infant rats.
- Findings emphasize the importance of lung-protective ventilation strategies.
- Further research is needed to confirm the relevance of these findings to human infants.
Background:
Intensive care practice calls for ventilator adjustments due to fast-changing clinical conditions in ventilated critically ill children. These adaptations include positive end-expiratory pressure (PEEP), fraction of inspired oxygen (FiO2), and respiratory rate (RR). It is unclear which alterations in ventilator settings trigger a significant systemic inflammatory response.
Methods:
Fourteen-day old Wistar rat pups were randomized to the following groups: (a) "control" with tidal volume ~8 mL/kg, PEEP 5 cmH2O, FiO2 0.4, RR 90 min-1, (b) "PEEP 1", (c) "PEEP 9" (d) "FiO2 0.21", (e) "FiO2 1.0", (f) "hypocapnia" with RR of 180 min-1, and (g) "hypercapnia" with RR of 60 min-1. Following 120 min of mechanical ventilation, plasma for inflammatory biomarker analyses was obtained by direct cardiac puncture at the end of the experiment.
Results:
Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were driven by FiO2 0.4 and 1.0 (P=0.02, P<0.01, respectively), tissue plasminogen activator inhibitor type-1 (tPAI-1) was increased by high PEEP (9 cmH2O, P<0.05) and hypocapnia (P<0.05), and TNF-α was significantly lower in hypercapnia (P<0.01). Tissue inhibitor of metalloproteinase-1 (TIMP-1), cytokine-induced neutrophil chemoattractant 1 (CINC-1), connective tissue growth factor (CTGF), and monocyte chemoattractant protein-1 (MCP-1) remained unaffected.
Conclusion:
Alterations of PEEP, FiO2, and respiratory frequency induced a significant systemic inflammatory response in plasma of infant rats. These findings underscore the importance of lung-protective ventilation strategies. However, future studies are needed to clarify whether ventilation induced systemic inflammation in animal models is pathophysiologically relevant to human infants.
More Related Videos
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-III
Pneumonia II: Pathophysiology

